The stock's rise snapped a four-day losing streak.

Fintel reports that on February 28, 2025, Stifel downgraded their outlook for Vertex (NasdaqGM:VERX) from Buy to Hold.

Vertex Pharmaceuticals (VRTX) stock in focus as company secures EU backing to expand label for its cystic fibrosis therapy ...

Vertex, Inc. (NASDAQ:VERX – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the thirteen research firms that are currently covering the company, MarketBeat.com reports.

The companies were two years into a four-year, $400 million agreement aimed at developing and marketing gene therapies ...

We recently compiled a list of the 10 Stocks Drop by Double Digits Mostly Due to Disappointing Earnings. In this article, we ...

Federal Territory of Kuala Lumpur, Malaysia, February 28, 2025 -- SurgeGraph, an AI writing tool focused on helping users ...

In Vermont, no day goes by without another news story about the lack of affordable, workforce, and senior housing.

About the company: SurgeGraph Vertex is an AI writing tool with a mission to help users grow their website traffic through ...

April users can now file in all 50 states; KSM launches IT services advisory; Expensify announces Expensify Travel; and other accounting tech news and updates.

Vertex Securities Ltd., incorporated in the year 1993, is a Small Cap company (having a market cap of Rs 32.71 Crore) operating in Financial Services sector. Vertex Securities Ltd. key ...